Cargando…
Autoantibody Discovery, Assay Development and Adoption: Death Valley, the Sea of Survival and Beyond
Dating to the discovery of the Lupus Erythematosus (LE) cell in 1948, there has been a dramatic growth in the discovery of unique autoantibodies and their cognate targets, all of which has led to the availability and use of autoantibody testing for a broad spectrum of autoimmune diseases. Most studi...
Autores principales: | Fritzler, Marvin J., Choi, May Y., Satoh, Minoru, Mahler, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8191456/ https://www.ncbi.nlm.nih.gov/pubmed/34122443 http://dx.doi.org/10.3389/fimmu.2021.679613 |
Ejemplares similares
-
The Utilization of Autoantibodies in Approaches to Precision Health
por: Fritzler, Marvin J., et al.
Publicado: (2018) -
Update on autoantibodies and related biomarkers in autoimmune inflammatory myopathies
por: Choi, May Y., et al.
Publicado: (2023) -
Rpp25 is a major target of autoantibodies to the Th/To complex as measured by a novel chemiluminescent assay
por: Mahler, Michael, et al.
Publicado: (2013) -
Deciphering the Autoantibody Response to the OJ Antigenic Complex
por: Fritzler, Marvin J., et al.
Publicado: (2023) -
Significance of Autoantibodies to Ki/SL as Biomarkers for Systemic Lupus Erythematosus and Sicca Syndrome
por: Mahler, Michael, et al.
Publicado: (2022)